Evidence map›Paper›PMID 24467257›Full record

Trial reportHealth psychology : official journal of the Division of Health Psychology, American Psychological Association2014

Multiple risk-behavior profiles of smokers with serious mental illness and motivation for change.

Judith J Prochaska, Sebastien C Fromont, Kevin Delucchi, Kelly C Young-Wolff, Neal L Benowitz, Stephen Hall, Thomas Bonas, Sharon M Hall

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Health psychology : official journal of the Division of Health Psychology, American Psychological Association, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Multiple Health Risk Behaviors in Young Adult Smokers: Stages of Change and Stability over Time.Annals of behavioral medicine : a publication of the Society of Behavioral Medicine · 2020
    Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Judith J ProchaskaStanford Prevention Research Center, Department of Medicine, Stanford University.
Sebastien C FromontDepartment of Psychiatry, University of California-San Francisco.
Kevin DelucchiDepartment of Psychiatry, University of California-San Francisco.
Kelly C Young-WolffStanford Prevention Research Center, Department of Medicine, Stanford University.
Neal L BenowitzDivision of Clinical Pharmacology, Departments of Medicine and Bioengineering & Therapeutic Sciences, University of California-San Francisco.
Stephen HallDepartment of Psychiatry, University of California-San Francisco.
Thomas BonasAlta Bates Summit Medical Center-Herrick.
Sharon M HallDepartment of Psychiatry, University of California-San Francisco.
University of California, San Francisco · USStanford University · US

Funding

TREATMENTS FOR COMPLEX PATIENTS IN NEW SETTINGSP50DA009253 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GUYDISH, JOSEPH R · 1994 to 2014
$28.2M
CARDIOVASCULAR DISEASE PREVENTION TRAINING PROGRAMT32HL007034 · NHLBI · STANFORD UNIVERSITY · PI GARDNER, CHRISTOPHER D · 1985 to 2020
$8.7M
Evaluation of Tobacco Treatment Strategies for Inpatient PsychiatryR01MH083684 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PROCHASKA, JUDITH J. · 2009 to 2013
$2.6M
Treatment of Complex Patients: Emphasis on NicotineK05DA016752 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HALL, SHARON M. · 2003 to 2012
$1.1M
Treating Tobacco Dependence in Inpatient PsychiatryK23DA018691 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PROCHASKA, JUDITH J. · 2005 to 2009
$769k
NHLBI NIH HHS T32 HL007034NIDA NIH HHS K05 DA016752NIDA NIH HHS K23 DA018691NIDA NIH HHS P50 DA009253NIDA NIH HHS P50DA09253NIMH NIH HHS R01 MH083684
6 · The paper itself

Abstract

objectiveIndividuals with serious mental illness (SMI) are dying on average 25 years prematurely. The leading causes are chronic preventable diseases. In the context of a tobacco-treatment trial, this exploratory study examined the behavioral risk profiles of adults with SMI to identify broader interventional needs.

methodRecruited from five acute inpatient psychiatry units, participants were 693 adult smokers (recruitment rate = 76%, 50% male, 45% Caucasian, age M = 39, 49% had income < $10,000) diagnosed with mood disorders (71%), substance-use disorders (63%), posttraumatic stress disorder (39%), psychotic disorders (25%), and attention deficit-hyperactivity disorder (25%). The Staging Health Risk Assessment, the primary measure used in this study, screened for risk status and readiness to change 11 health behaviors, referencing the period prior to acute hospitalization.

resultsParticipants averaged 5.2 (SD = 2.1) risk behaviors, including smoking (100%), high-fat diet (68%), inadequate fruits/vegetables (67%), poor sleep (53%), physical inactivity (52%), and marijuana use (46%). The percent prepared to change ranged from 23% for tobacco and marijuana to 76% for depression management. Latent class analysis differentiated three risk groups: the global higher risk group included patients elevated on all risk behaviors; the global lower risk group was low on all risks; and a mood and metabolic risk group, characterized by inactivity, unhealthy diet, sleep problems, and poor stress and depression management. The global higher risk group (11% of sample) was younger, largely male, and had the greatest number of risk behaviors and mental health diagnoses; had the most severe psychopathologies, addiction-treatment histories, and nicotine dependence; and the lowest confidence for quitting smoking and commitment to abstinence.

conclusionMost smokers with SMI engaged in multiple risks. Expanding targets to treat co-occurring risks and personalizing treatment to individuals' multibehavioral profiles may increase intervention relevance, interest, and impact on health.

Indexed as

Risk-TakingAdultCross-Sectional StudiesFemaleHealth BehaviorHumansMaleMental DisordersMiddle AgedMotivationSeverity of Illness IndexSmokingSmoking Cessation

Identifiers

PMID24467257
PMCPMC4425305
OpenAlexW1965027098

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.